Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析

◆英語タイトル:Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1686
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kyowa Kirin Co Ltd (4151) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kyowa Kirin Co Ltd (Kyowa Kirin), a subsidiary of Kirin Holdings Company Limited, is a research and development based biotechnology company. It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company operates through a network of subsidiaries in the US, Europe and Asia. Kyowa Kirin is headquartered in Tokyo, Japan.

Kyowa Kirin Co Ltd Key Recent Developments

Feb 05,2020 Kyowa Kirin announces its organization changes
Nov 27,2019 Ardelyx and Kyowa Kirin expand drug development partnership
Nov 26,2019 Kyowa Kirin announces organizational changes in quality assurance and pharmacovigilance functions
Jul 01,2019 Kyowa Kirin Corporate Website Renewal

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Kyowa Kirin Co Ltd – Key Facts
Kyowa Kirin Co Ltd – Key Employees
Kyowa Kirin Co Ltd – Key Employee Biographies
Kyowa Kirin Co Ltd – Major Products and Services
Kyowa Kirin Co Ltd – History
Kyowa Kirin Co Ltd – Company Statement
Kyowa Kirin Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Kyowa Kirin Co Ltd – Business Description
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
R&D Overview
Kyowa Kirin Co Ltd – Corporate Strategy
Kyowa Kirin Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Kyowa Kirin Co Ltd – Strengths
Kyowa Kirin Co Ltd – Weaknesses
Kyowa Kirin Co Ltd – Opportunities
Kyowa Kirin Co Ltd – Threats
Kyowa Kirin Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 05, 2020: Kyowa Kirin announces its organization changes
Nov 27, 2019: Ardelyx and Kyowa Kirin expand drug development partnership
Nov 26, 2019: Kyowa Kirin announces organizational changes in quality assurance and pharmacovigilance functions
Jul 01, 2019: Kyowa Kirin Corporate Website Renewal
Feb 05, 2019: Kyowa Hakko Kirin announces changes in global management structure
Feb 05, 2019: Kyowa Hakko Kirin announces organizational changes
Feb 05, 2019: Kyowa Hakko Kirin announces changes in the Executive Directors
Feb 05, 2019: Kyowa Kirin Announces CI Logotype Change
Feb 05, 2019: Kyowa Hakko Kirin announces consolidated financial results for the fiscal year ended December 31, 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Kyowa Kirin Co Ltd, Key Facts
Kyowa Kirin Co Ltd, Key Employees
Kyowa Kirin Co Ltd, Key Employee Biographies
Kyowa Kirin Co Ltd, Major Products and Services
Kyowa Kirin Co Ltd, History
Kyowa Kirin Co Ltd, Other Locations
Kyowa Kirin Co Ltd, Subsidiaries
Kyowa Kirin Co Ltd, Joint Venture
Kyowa Kirin Co Ltd, Key Competitors
Kyowa Kirin Co Ltd, Ratios based on current share price
Kyowa Kirin Co Ltd, Annual Ratios
Kyowa Kirin Co Ltd, Annual Ratios (Cont...1)
Kyowa Kirin Co Ltd, Annual Ratios (Cont...2)
Kyowa Kirin Co Ltd, Interim Ratios
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Kyowa Kirin Co Ltd, Performance Chart (2015 - 2019)
Kyowa Kirin Co Ltd, Ratio Charts
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cisco Systems, Inc (CSCO)-石油・ガス分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Eiger BioPharmaceuticals Inc (EIGR):企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • China Resources Wandong Medical Equipment Co Ltd (600055):医療機器:M&Aディール及び事業提携情報
    Summary China Resources Wandong Medical Equipment Co Ltd (Wandong Medical Equipment), formerly Beijing Wandong Medical Equipment Co Ltd, a subsidiary of Beijing Pharmaceutical Group Co Ltd, is a medical device company that develops and markets medical devices and equipment. The company’s products in …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Deluxe Corporation
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The University of New South Wales-製薬・医療分野:企業M&A・提携分析
    Summary The University of New South Wales (UNSW Australia) is an academic university that offer research and education services. The university’s educational services include fine arts education, design, media arts, art and design, art history, theory and art administration, social sciences, enginee …
  • Hybio Pharmaceutical Co Ltd (300199):製薬・医療:M&Aディール及び事業提携情報
    Summary Hybio Pharmaceutical Co Ltd (Hybio) is a peptide pharmaceutical company that develops and manufactures of polypeptide drugs. The company offers peptide finished dosage products and peptide active pharmaceutical ingredients. Its finished dosage products include desmopressin for injection, ter …
  • Ability Pharmaceuticals SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly AB Therapeutics SL is a biopharmaceutical company that discovers and develops human therapeutics for the treatment of cancer and other indications. The company’s lead pipeline drug candidate includes ABTL0812, a new drug class of small mo …
  • Eucatex SA Industria e Comercio:企業の戦略・SWOT・財務情報
    Eucatex SA Industria e Comercio - Strategy, SWOT and Corporate Finance Report Summary Eucatex SA Industria e Comercio - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Oglethorpe Power Corporation:企業の発電所・SWOT分析2018
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Alliance Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Alliance Oil Company Ltd (AOC) is an integrated oil and gas company. It explores for, extracts, and produces crude oil and gas; refines oil; and transports and sells oil products. The company has oil and gas exploration and production fields in the Timano-Pechora, Volga-Urals and Tomsk regio …
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Smith & Nephew plc:企業のM&A・事業提携・投資動向
    Smith & Nephew plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smith & Nephew plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Highmark Inc:企業の戦略的SWOT分析
    Highmark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Medigen Biotechnology Corp (3176):企業の財務・戦略的SWOT分析
    Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Caltex Australia Ltd (CTX):企業の財務・戦略的SWOT分析
    Caltex Australia Ltd (CTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Solargiga Energy Holdings Ltd (757):電力:M&Aディール及び事業提携情報
    Summary Solargiga Energy Holdings Ltd (Solargiga Energy), a subsidiary of Wafer Works Corp is a renewable energy equipment manufacturer that develops and markets monocrystalline silicon products. The company manufactures monocrystalline silicon solar ingots and wafers, solar cells and photovoltaic m …
  • Dillard’s Inc:戦略・SWOT・企業財務分析
    Dillard's Inc - Strategy, SWOT and Corporate Finance Report Summary Dillard's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Advantage Oil & Gas Ltd. (AAV)-石油・ガス分野:企業M&A・提携分析
    Summary Advantage Oil & Gas Ltd. (Advantage Oil) is an upstream company that exploits, develops, acquires, and produces natural gas and liquids in Alberta. Its exploitation and development program is focused at Glacier. The company’s acreage is spread throughout the Western Canadian Sedimentary Basi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆